Jiangsu Hengrui Me. traded at 50.43 this Friday November 6th, increasing 0.24 or 0.48 percent since the previous trading session. Looking back, over the last four weeks, Jiangsu Hengrui gained 7.28 percent. Over the last 12 months, its price fell by 18.11 percent. Looking ahead, we forecast Jiangsu Hengrui Me. to be priced at 47.29 by the end of this quarter and at 43.95 in one year, according to Trading Economics global macro models projections and analysts expectations.
Jiangsu Hengrui Pharmaceuticals Co Ltd is a China-based company principally engaged in the manufacture and distribution of pharmaceutical tablets, injections and raw materials. The Company's main products portfolio consists of antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents, antibiotics, specialty infusions and others. The Company distributes its products within domestic market and to overseas markets.